NanoString Technologies (BMV:NSTG *) - Cotización, noticias y análisis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Resumen de acción NSTG *

Develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific.

Acerca de la empresa

Análisis fundamental de NSTG *
Puntuación del snowflake
Valoración	4/6
Crecimiento futuro	1/6
Rendimiento pasado	0/6
Salud financiera	0/6
Dividendos	0/6

Recompensas

Cotiza un 89.1% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los ingresos de 16.2%

Análisis de riesgos

Patrimonio neto negativo

Acciones altamente ilíquidas

No tiene una capitalización de mercado significativa (MX$38M)

Los accionistas han sido diluidos en el último año

+ 2 riesgos adicionales

Competidores de NS Wind Down Co., Inc.

DNA Chip Research

TSE:2397

JP¥5.3b

Cryosite

ASX:CTE

AU$39.0m

Magle Chemoswed Holding

OM:MAGLE

SEK 416.9m

Hyundai ADM Bio

KOSDAQ:A187660

₩64.3b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de NanoString Technologies
Precios históricos de las acciones
Precio actual de la acción	US$29.32
Máximo en las últimas 52 semanas	US$233.89
Mínimo de 52 semanas	US$29.32
Beta	1.32
1Cambio en 1 mes	0%
Variación en 3 meses	n/a
Cambio de 1 año	n/a
3Variación en 3 años	n/a
Variación en 5 años	n/a
Variación desde la OPV	-96.72%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	NSTG *	MX Life Sciences	Mercado MX
7D	0%	0%	0%
1Y	n/a	0%	0%

Rentabilidad vs. Industria: Datos insuficientes para determinar los resultados de NSTG * en comparación con el sector MX Life Sciences .

Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de NSTG * frente al mercado MX.

Volatilidad de los precios

Is NSTG *'s price volatile compared to industry and market?
NSTG * volatility
NSTG * Average Weekly Movement	n/a
Life Sciences Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in MX Market	0%
10% least volatile stocks in MX Market	0%

Precio estable de las acciones: NSTG * no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de NSTG * en el último año.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2003	550	Brad Gray	www.nanostring.com

Resumen de fundamentos de NS Wind Down Co., Inc.

¿Cómo se comparan los beneficios e ingresos de NanoString Technologies con su capitalización de mercado?
Estadísticas fundamentales de NSTG *
Capitalización bursátil	Mex$652.58m
Beneficios(TTM)	-Mex$2.83b
Ingresos (TTM)	Mex$2.76b

0.2x

Ratio precio-ventas (PS)

-0.2x

Ratio precio-beneficio (PE)

¿Está NSTG * sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de NSTG *
Ingresos	US$162.47m
Coste de los ingresos	US$104.44m
Beneficio bruto	US$58.04m
Otros gastos	US$224.47m
Beneficios	-US$166.43m

Últimos beneficios comunicados

Sep 30, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	-3.46
Margen bruto	35.72%
Margen de beneficio neto	-102.44%
Ratio deuda/patrimonio	-450.4%

¿Cómo se ha desempeñado NSTG * a largo plazo?

Ver rendimiento histórico y comparativa

This company listing is no longer active

Resumen de acción NSTG *

Recompensas

Análisis de riesgos

Competidores de NS Wind Down Co., Inc.

TSE:2397

JP¥5.3b

ASX:CTE

AU$39.0m

OM:MAGLE

SEK 416.9m

KOSDAQ:A187660

₩64.3b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

Recent updates

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

The Nasdaq Stock Market to Delist the Common Stock of Nanostring Technologies

NanoString Technologies, Inc. announced delayed annual 10-K filing

Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million.

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index

Motion for Joint Administration Approved for NanoString Technologies, Inc.

Motion for Joint Administration Filed by NanoString Technologies, Inc.

NanoString Technologies, Inc. Filed for Bankruptcy

Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager

NanoString Technologies Receives Non-Compliance Notice from Nasdaq

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

NanoString Technologies, Inc. to Report Q3, 2023 Results on Nov 06, 2023

NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

Nanostring Appoints Todd Garland as Chief Commercial Officer

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: US$0.92 loss per share (vs US$0.84 loss in 2Q 2022)

NanoString Technologies, Inc. Reiterates Earnings Guidance for the Full Year 2023

Delaware District Court Permits NanoString Technologies, Inc.'s Counterclaims That 10x Genomics and Harvard Violated the Antitrust Laws

NanoString Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

10X Genomics, Inc. Files New Patent Litigation Against Nanostring Technologies, Inc. and Vizgen, Inc. in the European Unified Patent Court

10X Genomics Wins Permanent Injunction Against Nanostring's CosMX Products

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

Independent Director recently bought Mex$2.2m worth of stock

Full year 2022 earnings released: US$3.44 loss per share (vs US$2.54 loss in FY 2021)

NanoString Technologies, Inc. to Report Q4, 2022 Results on Feb 28, 2023

NanoString Technologies, Inc. Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology

NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager

NanoString Technologies, Inc. Provides Product and Service Revenue Guidance for the Fourth Quarter and Full Year 2022

CEO, President & Director recently bought Mex$9.8m worth of stock

NanoString Technologies, Inc Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

Third quarter 2022 earnings released: US$0.79 loss per share (vs US$0.69 loss in 3Q 2021)

Now 21% undervalued after recent price drop

NanoString Technologies, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Now 30% undervalued

Now 20% undervalued

Now 21% undervalued after recent price drop

Now 20% undervalued

Nanostring Technologies, Inc. Provides Revenue Guidance for 2022

Second quarter 2022 earnings released: US$0.84 loss per share (vs US$0.60 loss in 2Q 2021)

NanoString Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022

NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

Nanostring Technologies, Inc. Announces Plans to Commercially Unveil the Cosmx™ Spatial Molecular Imager

NanoString Technologies, Inc. Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing

NanoString Technologies, Inc. Announces Resignation of Robert Hershberg from the Board

NanoString Technologies, Inc. Launches New nCounter Pro Analysis System

NanoString Technologies, Inc. Announces Release of a Fully Automated GeoMx RNA Protocol on BOND RX Research Staining Systems

NanoString Technologies, Inc. to Report Q4, 2021 Results on Mar 01, 2022

Nanostring Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021

Rentabilidad de los accionistas

Volatilidad de los precios

Acerca de la empresa

Resumen de fundamentos de NS Wind Down Co., Inc.